Adriana Arango-Luque DMD, MSE , Daniela Yucumá MD, MPH , Camilo E. Castañeda MD (Neurologist) , Jaime Espin LLB, MHE, PhD in Economics , Francisco Becerra-Posada MD, MPH, DrPH
{"title":"拉丁美洲疫苗平等获取的分级定价和替代机制:文献综述","authors":"Adriana Arango-Luque DMD, MSE , Daniela Yucumá MD, MPH , Camilo E. Castañeda MD (Neurologist) , Jaime Espin LLB, MHE, PhD in Economics , Francisco Becerra-Posada MD, MPH, DrPH","doi":"10.1016/j.vhri.2024.01.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To review and describe alternative strategies for the supply of vaccines in Latin America.</p></div><div><h3>Methods</h3><p>We conducted a narrative review to explore and describe alternatives for equitable vaccine access in Latin America. We searched and considered the main access strategies reported in the literature through PubMed, Science Direct, and Google Scholar. Additionally, we reviewed the web sites of key stakeholders. The search was conducted using the following keywords: (“access” or “availability” or “acquisition” or “affordability” or “tiered pricing”) and (“vaccine”). Subsequently, documents that met the inclusion criteria were selected. Finally, findings were grouped by means of a thematic analysis and an interpretative synthesis.</p></div><div><h3>Results</h3><p>Twenty-four publications were included. We identified 5 main topics: current supply strategies, challenges for the acquisition of vaccines, vaccine prices equity, alternative supply strategies, and the advantages and impact of a tiered pricing strategy.</p></div><div><h3>Conclusions</h3><p>Our review suggests that tiered pricing can be an tool for accelerating the process of introducing vaccines in low-income countries at affordable prices and for countries that do not adhere to the current procurement mechanisms or are not eligible for Vaccine Alliance because giving countries prices for vaccines that reflect their ability to pay can result in better programmatic and financial planning for the purchase of these vaccines, and in return, vaccine manufacturers can gain access to wider markets However, this model has not been z improve access to vaccines that are aimed only at developing countries, mainly because the market in these countries is not profitable for producers.</p></div>","PeriodicalId":23497,"journal":{"name":"Value in health regional issues","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature\",\"authors\":\"Adriana Arango-Luque DMD, MSE , Daniela Yucumá MD, MPH , Camilo E. Castañeda MD (Neurologist) , Jaime Espin LLB, MHE, PhD in Economics , Francisco Becerra-Posada MD, MPH, DrPH\",\"doi\":\"10.1016/j.vhri.2024.01.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>To review and describe alternative strategies for the supply of vaccines in Latin America.</p></div><div><h3>Methods</h3><p>We conducted a narrative review to explore and describe alternatives for equitable vaccine access in Latin America. We searched and considered the main access strategies reported in the literature through PubMed, Science Direct, and Google Scholar. Additionally, we reviewed the web sites of key stakeholders. The search was conducted using the following keywords: (“access” or “availability” or “acquisition” or “affordability” or “tiered pricing”) and (“vaccine”). Subsequently, documents that met the inclusion criteria were selected. Finally, findings were grouped by means of a thematic analysis and an interpretative synthesis.</p></div><div><h3>Results</h3><p>Twenty-four publications were included. We identified 5 main topics: current supply strategies, challenges for the acquisition of vaccines, vaccine prices equity, alternative supply strategies, and the advantages and impact of a tiered pricing strategy.</p></div><div><h3>Conclusions</h3><p>Our review suggests that tiered pricing can be an tool for accelerating the process of introducing vaccines in low-income countries at affordable prices and for countries that do not adhere to the current procurement mechanisms or are not eligible for Vaccine Alliance because giving countries prices for vaccines that reflect their ability to pay can result in better programmatic and financial planning for the purchase of these vaccines, and in return, vaccine manufacturers can gain access to wider markets However, this model has not been z improve access to vaccines that are aimed only at developing countries, mainly because the market in these countries is not profitable for producers.</p></div>\",\"PeriodicalId\":23497,\"journal\":{\"name\":\"Value in health regional issues\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Value in health regional issues\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212109924000116\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in health regional issues","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212109924000116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
方法 我们进行了一项叙述性综述,以探索和描述拉丁美洲公平获取疫苗的替代方案。我们通过 PubMed、Science Direct 和 Google Scholar 搜索并研究了文献中报道的主要获取策略。此外,我们还浏览了主要利益相关者的网站。搜索时使用了以下关键词:("获取 "或 "可用性 "或 "获得 "或 "可负担性 "或 "分级定价")和("疫苗")。随后,筛选出符合纳入标准的文件。最后,通过专题分析和解释性综述对研究结果进行了分组。我们确定了 5 个主要议题:当前的供应策略、疫苗采购面临的挑战、疫苗价格公平性、替代供应策略以及分级定价策略的优势和影响。结论我们的综述表明,分级定价可作为一种工具,加快低收入国家以可承受的价格引进疫苗的进程,并适用于不遵守现行采购机制或不符合疫苗联盟条件的国家,因为给予各国反映其支付能力的疫苗价格可使购买这些疫苗的计划和财务规划更加完善,而作为回报,疫苗生产商可获得更广泛的市场。
Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature
Objectives
To review and describe alternative strategies for the supply of vaccines in Latin America.
Methods
We conducted a narrative review to explore and describe alternatives for equitable vaccine access in Latin America. We searched and considered the main access strategies reported in the literature through PubMed, Science Direct, and Google Scholar. Additionally, we reviewed the web sites of key stakeholders. The search was conducted using the following keywords: (“access” or “availability” or “acquisition” or “affordability” or “tiered pricing”) and (“vaccine”). Subsequently, documents that met the inclusion criteria were selected. Finally, findings were grouped by means of a thematic analysis and an interpretative synthesis.
Results
Twenty-four publications were included. We identified 5 main topics: current supply strategies, challenges for the acquisition of vaccines, vaccine prices equity, alternative supply strategies, and the advantages and impact of a tiered pricing strategy.
Conclusions
Our review suggests that tiered pricing can be an tool for accelerating the process of introducing vaccines in low-income countries at affordable prices and for countries that do not adhere to the current procurement mechanisms or are not eligible for Vaccine Alliance because giving countries prices for vaccines that reflect their ability to pay can result in better programmatic and financial planning for the purchase of these vaccines, and in return, vaccine manufacturers can gain access to wider markets However, this model has not been z improve access to vaccines that are aimed only at developing countries, mainly because the market in these countries is not profitable for producers.